GW Pharmaceuticals Ltd - Company Profile
Powered by
All the data and insights you need on GW Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date GW Pharmaceuticals Ltd Strategy Report
- Understand GW Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on GW Pharmaceuticals Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EA201290975A8 | Application | ПРИМЕНЕНИЕ ФИТОКАННАБИНОИДА КАННАБИДИВАРИНА (CBDV) ДЛЯ ЛЕЧЕНИЯ ЭПИЛЕПСИИ | A61K31/05; A61K31/19; A61K31/352; A61K31/40; A61K31/515; A61K36/185; A61K45/06; A61P25/08; A61P43/00 | February 28, 2017 |
RU2563143C2 | Grant | APPLICATION OF ONE OR COMBINATION OF PHYTOCANNABINOIDS FOR TREATMENT OF EPILEPSY | A61K2121/00; A61K31/05; A61K31/352; A61K36/185; A61K9/0019; A61P25/00; A61P25/08; A61P25/10; A61P25/12; A61P43/00 | September 20, 2015 |
US20140335208A1 | Application | TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS | A61K31/155; A61K31/352; A61K31/4439; A61K36/185; A61K45/06; A61P3/10 | November 13, 2014 |
RU2012103603A | Application | ПРИМЕНЕНИЕ ОДНОГО ИЛИ КОМБИНАЦИИ ФИТОКАННАБИНОИДОВ ДЛЯ ЛЕЧЕНИЯ ЭПИЛЕПСИИ | A61K2121/00; A61K31/05; A61K31/352; A61K36/185; A61K9/0019; A61P25/00; A61P25/08; A61P25/10; A61P25/12; A61P43/00 | August 10, 2013 |
EA201290975A1 | Application | ПРИМЕНЕНИЕ ФИТОКАННАБИНОИДА КАННАБИДИВАРИНА (CBDV) ДЛЯ ЛЕЧЕНИЯ ЭПИЛЕПСИИ | A61K31/05; A61K31/19; A61K31/352; A61K31/40; A61K31/515; A61K36/185; A61K45/06; A61P25/08; A61P43/00 | April 30, 2013 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer